Abstract
Despite an improvement in the efficacy of chemotherapeutic agents, the outcome of patients with prostate cancer remains poor. MicroRNA (miRNA/miR)-139......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
